NCT05765409 (TIMCA) is a NA clinical trial of TIMCA in Cannabis Use Disorder, sponsored by Centre Hospitalier St Anne.

Who is sponsoring NCT05765409?

NCT05765409 is sponsored by Centre Hospitalier St Anne.

What drugs are being tested in NCT05765409?

Interventions in NCT05765409: TIMCA, Treatment as Usual.

What condition does NCT05765409 study?

NCT05765409 studies Cannabis Use Disorder.

Is NCT05765409 still recruiting?

NCT05765409 is currently status unknown. Last updated 13 March 2023.

Last reviewed 2023-03-13 · How we verify

NCT05765409: TIMCA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of the Effectiveness of an Integrative Therapy for Cannabis Misuse in Adolescents

Status unknown NA Last updated 13 March 2023

What this trial tests

NA trial testing TIMCA in Cannabis Use Disorder in 100 participants. Status unknown.

Timeline

15 February 2023

Primary endpoint
9 June 2025

9 June 2025

Quick facts

Lead sponsor	Centre Hospitalier St Anne
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	15 February 2023
Primary completion	9 June 2025
Estimated completion	9 June 2025
Sites	1 location across France

Drugs / interventions tested

TIMCA
Treatment as Usual

Conditions studied

Cannabis Use Disorder — all drugs for Cannabis Use Disorder →

Sponsor

Centre Hospitalier St Anne

Who can join

Adults 14 to 20, any sex, with Cannabis Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate an Integrative Therapy for Adolescent Cannabis Use (TIMCA), integrating elements of Motivational Interviewing (MI), Cognitive Behavioral Therapies (CBT) and an Attachment-Based Intervention (ABI), (IBA),compared to Treatment As Usual (TAU) on cannabis use. The secondary objectives of the study are: To assess the effectiveness of the TIMCA, in comparison to the TAU, on: (1) Relationship quality with parents, (2) Relationship quality with closest friend, (3) Emotional regulation strategies, (4) Depressive symptomatology, (5) Anxiety symptomatology, (6) Adherence to therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cannabis Use Disorder

Currently open trials in the same condition.

NCT07523633 — Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder · Phase 2 · recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
NCT07218471 — Cannabis Reduction and Functional Outcomes · NA · recruiting
NCT07184983 — RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative · NA · recruiting
NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting

Other Centre Hospitalier St Anne trials

Trials by the same sponsor.

NCT07340736 — Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Corr · NA · not yet recruiting
NCT07376473 — Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas · not yet recruiting
NCT07395323 — Impact of Relaxation Sessions Using a Virtual Reality Application on the Sleep Quality of Caregivers Working Night Shift · NA · not yet recruiting
NCT07283458 — Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS) · NA · not yet recruiting
NCT07144956 — Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05765409 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier St Anne
Last refreshed: 13 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05765409.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing